Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
839kB |
Other (Supporting Information)
742kB |
Item Type: | Article |
---|---|
Title: | Effect of vitamin D supplementation on N-glycan branching and cellular immunophenotypes in MS |
Creators Name: | Bäcker-Koduah, P., Infante-Duarte, C., Ivaldi, F., Uccelli, A., Bellmann-Strobl, J., Wernecke, K.D., Sy, M., Demetriou, M., Dörr, J., Paul, F. and Brandt, A.U. |
Abstract: | OBJECTIVE: To investigate the effect of cholecalciferol (vitamin D3) supplementation on peripheral immune cell frequency and N-glycan branching in patients with relapsing-remitting multiple sclerosis (RRMS). METHODS: Exploratory analysis of high-dose (20 400 IU) and low-dose (400 IU) vitamin D3 supplementation taken every other day of an 18-month randomized controlled clinical trial including 38 RRMS patients on stable immunomodulatory therapy (NCT01440062). We investigated cholecalciferol treatment effects on N-glycan branching using L-PHA stain (phaseolus vulgaris leukoagglutinin) at 6 months and frequencies of T-, B-, and NK-cell subpopulations at 12 months with flow cytometry. RESULTS: High-dose supplementation did not change CD3+ T cell subsets, CD19+ B cells subsets, and NK cells frequencies, except for CD8+ T regulatory cells, which were reduced in the low-dose arm compared to the high-dose arm at 12 months. High-dose supplementation decreased N-glycan branching on T and NK cells, measured as L-PHA mean fluorescence intensity (MFI). A reduction of N-glycan branching in B cells was not significant. In contrast, low-dose supplementation did not affect N-glycan branching. Changes in N-glycan branching did not correlate with cell frequencies. INTERPRETATION: Immunomodulatory effect of vitamin D may involve regulation of N-glycan branching in vivo. Vitamin D3 supplementation did at large not affect the frequencies of peripheral immune cells. |
Keywords: | B-Lymphocyte Subsets, Cholecalciferol, Dietary Supplements, Immunologic Factors, Natural Killer Cells, Polysaccharides, Relapsing-Remitting Multiple Sclerosis, T-Lymphocyte Subsets, Treatment Outcome |
Source: | Annals of Clinical and Translational Neurology |
ISSN: | 2328-9503 |
Publisher: | Wiley |
Volume: | 7 |
Number: | 9 |
Page Range: | 1628-1641 |
Date: | September 2020 |
Official Publication: | https://doi.org/10.1002/acn3.51148 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page